Title of Collaborative Activity: |
NIDA Consultative Assistance to the FDA Regarding Domestic Scheduling of New Medications |
Description of Collaborative Activity: |
Subsequent to the filing of a New Drug Application by a pharmaceutical company, the FDA prepares an “8-factor analysis” of abuse liability and prepares a draft scheduling recommendation. NIDA reviews the draft documents and provides advice regarding potential revisions. |
Type of Collaborative Activity: |
Select Type of Collaborative Activity
|
Year the Collaborative Activity Originated: |
Unknown |
NIH Participating Institutes/Centers/Office of the Director: |
NIDA |
HHS Agency Collaborators on this Activity: |
FDA |
